申请人:The Upjohn Company
公开号:US04547499A1
公开(公告)日:1985-10-15
2,4-Dihydro-2-(omega-aminoalkyl)-1H-[1,2,4]triazolo[3,4-c][1,4]benzoxazin-1 -ones of the formula ##STR1## where n and -NRR are as defined in the specification, e.g., 2-[4-[4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperadinyl]butyl]-2,4-dih ydro-1H-[1,2,4]triazolo[3,4-c][1,4]benzoxazin-1-one, are disclosed. They are useful for treating hypertension or allergy conditions in humans and valuable animals.
本发明公开了以下结构的2,4-Dihydro-2-(ω-氨基烷基)-1H-[1,2,4]三唑并[3,4-c][1,4]苯并噁唑-1-酮(式中n和-NRR如规范中定义),例如2-[4-[4-(2,3-二氢-2-氧代-1H-苯并咪唑-1-基)哌啶基]丁基]-2,4-二氢-1H-[1,2,4]三唑并[3,4-c][1,4]苯并噁唑-1-酮。它们适用于治疗人类和有价值动物的高血压或过敏症状。